Mark Chin, Insider at Pyxis Oncology, Inc. (PYXS), sold 3,491,522 shares at $3.05 ($10.6M) on 2022-04-21, disclosed to the SEC on 2022-04-25.
Open-market sale of $10.6M PYXS by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.05 | 1,745,761 | $5.3M | 50.0% |
| 2 | $3.05 | 1,745,761 | $5.3M | 50.0% |
| Total | $3.05 avg | 3,491,522 | $10.6M | 100% |
| Filing → |
| IMRA | BUY | 2020-03-16 | $3.0M | — | Filing → |
| HARP | SELL | 2019-12-17 | $1.2M | — | Filing → |
| HARP | SELL | 2019-12-10 | $10.1M | — | Filing → |